Evidence map›Paper›PMID 39103319›Full record

ArticleNature communications2024

SR-TWAS: leveraging multiple reference panels to improve transcriptome-wide association study power by ensemble machine learning.

Randy L Parrish, Aron S Buchman, Shinya Tasaki, Yanling Wang, Denis Avey, Jishu Xu, Philip L De Jager, David A Bennett, Michael P Epstein, Jingjing Yang

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Exploring the Neuroprotective Effects of Walnut (International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Randy L ParrishCenter for Computational and Quantitative Genetics, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID 0009-0009-6836-4496
Aron S BuchmanRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, USA.ORCID 0000-0002-6426-2742
Shinya TasakiRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, USA.
Yanling WangRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, USA.ORCID 0000-0002-8589-4239
Denis AveyRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, USA.
Jishu XuRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, USA.
Philip L De JagerCenter for Translational and Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, 10032, USA.ORCID 0000-0002-8057-2505
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, USA.
Michael P EpsteinCenter for Computational and Quantitative Genetics, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA.ORCID 0000-0001-9647-9738
Jingjing YangCenter for Computational and Quantitative Genetics, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, 30322, USA. jingjing.yang@emory.edu.ORCID 0000-0002-4191-4138

Funding

Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targetsU01AG061356 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2018 to 2022
$13.7M
Pathway discovery, validation and compound identification for Alzheimer's disease - SupplementU01AG046152 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2013 to 2017
$13.6M
Genetic Epidemiology of Cognitive Decline in an Aging Population SampleR01AG030146 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI EVANS, DENIS A · 2007 to 2018
$6.2M
Impaired Gait in Older Adults: Pathologies of Alzheimer's disease and Related DisordersR01AG056352 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BUCHMAN, ARON S · 2017 to 2021
$3.5M
Exploring the Role of the Brain Transcriptome in Cognitive DeclineR01AG036836 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI DE JAGER, PHILIP L · 2011 to 2014
$2.9M
Quantitative Genetic Models for Exploring Missing Heritability of Alzheimer's DiseaseRF1AG071170 · NIA · EMORY UNIVERSITY · PI CUTLER, DAVID JOSEPH, EPSTEIN, MICHAEL PHILIP · 2020 to 2020
$2.9M
Novel Bayesian statistical tools for integrating multi-omics data to help elucidate the genomic etiology of complex phenotypesR35GM138313 · NIGMS · EMORY UNIVERSITY · PI YANG, JINGJING · 2020 to 2024
$1.9M
Statistical Tests for Mapping Genetic Determinants of Complex TraitsR01GM117946 · NIGMS · EMORY UNIVERSITY · PI EPSTEIN, MICHAEL PHILIP, GHOSH, DEBASHIS · 2016 to 2019
$1.2M
NIA NIH HHS P30 AG010161NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG030146NIA NIH HHS R01 AG036836NIA NIH HHS R01 AG056352NIA NIH HHS RF1 AG071170NIA NIH HHS U01 AG032984NIA NIH HHS U01 AG046152NIA NIH HHS U01 AG061356NIGMS NIH HHS R01 GM117946NIGMS NIH HHS R35 GM138313U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM117946U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM138313U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) RF1AG071170
6 · The paper itself

Abstract

Multiple reference panels of a given tissue or multiple tissues often exist, and multiple regression methods could be used for training gene expression imputation models for transcriptome-wide association studies (TWAS). To leverage expression imputation models (i.e., base models) trained with multiple reference panels, regression methods, and tissues, we develop a Stacked Regression based TWAS (SR-TWAS) tool which can obtain optimal linear combinations of base models for a given validation transcriptomic dataset. Both simulation and real studies show that SR-TWAS improves power, due to increased training sample sizes and borrowed strength across multiple regression methods and tissues. Leveraging base models across multiple reference panels, tissues, and regression methods, our real studies identify 6 independent significant risk genes for Alzheimer's disease (AD) dementia for supplementary motor area tissue and 9 independent significant risk genes for Parkinson's disease (PD) for substantia nigra tissue. Relevant biological interpretations are found for these significant risk genes.

Indexed as

Alzheimer DiseaseGenome-Wide Association StudyMachine LearningParkinson DiseaseTranscriptomeDementiaGene Expression ProfilingGenetic Predisposition to DiseaseHumansSubstantia Nigra

Identifiers

PMID39103319
PMCPMC11300466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.